TRCT
EHC icon

Tower Research Capital (TRC)’s Encompass Health EHC Stock Holding History

Tower Research Capital (TRC)’s Portfolio EHC Stock Details EHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$330K Sell
3,409
-913
-21% -$93.6K 0.01% 1232
2025
Q4 		$459K Sell
4,322
-979
-18% -$113K 0.01% 875
2025
Q3 		$673K Buy
5,301
+1,778
+50% +$212K 0.02% 687
2025
Q2 		$432K Sell
3,523
-514
-13% -$58.7K 0.01% 1103
2025
Q1 		$409K Sell
4,037
-6,561
-62% -$641K 0.01% 953
2024
Q4 		$979K Buy
10,598
+6,169
+139% +$606K 0.02% 634
2024
Q3 		$428K Buy
4,429
+485
+12% +$43.6K 0.01% 976
2024
Q2 		$338K Sell
3,944
-2,490
-39% -$209K 0.01% 1650
2024
Q1 		$531K Sell
6,434
-5,824
-48% -$427K 0.01% 832
2023
Q4 		$818K Sell
12,258
-404
-3% -$26.2K 0.01% 995
2023
Q3 		$850K Buy
12,662
+3,964
+46% +$273K 0.03% 604
2023
Q2 		$589K Buy
8,698
+5,896
+210% +$370K 0.02% 867
2023
Q1 		$152K Buy
2,802
+535
+24% +$31.1K ﹤0.01% 1530
2022
Q4 		$136K Sell
2,267
-7,336
-76% -$399K 0.01% 1586
2022
Q3 		$434K Buy
9,603
+519
+6% +$26K 0.01% 1256
2022
Q2 		$405K Buy
9,084
+815
+10% +$41.8K 0.01% 1270
2022
Q1 		$468K Sell
8,269
-246
-3% -$12.8K ﹤0.01% 1189
2021
Q4 		$442K Buy
8,515
+3,144
+59% +$162K 0.01% 1196
2021
Q3 		$321K Sell
5,371
-4,090
-43% -$257K 0.01% 1335
2021
Q2 		$587K Sell
9,461
-564
-6% -$37.6K 0.02% 1053
2021
Q1 		$653K Sell
10,025
-16,459
-62% -$1.07M 0.01% 1023
2020
Q4 		$1.74M Sell
26,484
-15,691
-37% -$923K 0.05% 258
2020
Q3 		$2.18M Buy
42,175
+8,016
+23% +$411K 0.02% 339
2020
Q2 		$1.68M Buy
+34,159
New +$1.84M 0.07% 282
2020
Q1 		– Sell
-8,201
Closed -$452K – 3240
2019
Q4 		$452K Buy
8,201
+7,383
+903% +$401K 0.04% 294
2019
Q3 		$41K Sell
818
-8,573
-91% -$431K ﹤0.01% 1936
2019
Q2 		$474K Buy
9,391
+2,377
+34% +$115K 0.03% 485
2019
Q1 		$326K Buy
7,014
+5,506
+365% +$279K 0.02% 879
2018
Q4 		$74K Sell
1,508
-13,408
-90% -$763K 0.01% 1086
2018
Q3 		$925K Buy
14,916
+13,530
+976% +$823K 0.07% 226
2018
Q2 		$75K Sell
1,386
-3,475
-71% -$174K ﹤0.01% 1612
2018
Q1 		$221K Buy
4,861
+1,546
+47% +$66.3K 0.02% 833
2017
Q4 		$130K Sell
3,315
-11,022
-77% -$419K 0.02% 757
2017
Q3 		$529K Buy
+14,337
New +$511K 0.04% 243
2017
Q2 		– Sell
-251
Closed -$9.19K – 2881
2017
Q1 		$9K Sell
251
-2,414
-91% -$79.3K ﹤0.01% 1840
2016
Q4 		$87K Buy
2,665
+1,252
+89% +$40.6K 0.01% 1051
2016
Q3 		$46K Sell
1,413
-4,856
-77% -$157K ﹤0.01% 1192
2016
Q2 		$194K Buy
6,269
+5,105
+439% +$160K 0.02% 679
2016
Q1 		$35K Buy
1,164
+654
+128% +$18.1K 0.01% 967
2015
Q4 		$14K Buy
+510
New +$14.5K ﹤0.01% 1679
2015
Q3 		– Sell
-2,544
Closed -$93K – 4173
2015
Q2 		$93K Sell
2,544
-3,599
-59% -$128K 0.01% 898
2015
Q1 		$217K Buy
6,143
+5,978
+3,623% +$205K 0.03% 378
2014
Q4 		$5K Sell
165
-3,299
-95% -$103K ﹤0.01% 2701
2014
Q3 		$102K Buy
3,464
+974
+39% +$29.7K 0.01% 919
2014
Q2 		$71K Buy
+2,490
New +$69.4K 0.01% 1079
2014
Q1 		– Sell
-1,363
Closed -$36K – 4556
2013
Q4 		$36K Sell
1,363
-13,835
-91% -$385K 0.01% 1685
2013
Q3 		$417K Buy
+15,198
New +$390K 0.04% 377

Other funds holding EHC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Tower Research Capital (TRC)'s EHC Position: Q1 2026 in Review

Tower Research Capital (TRC) reduced its Encompass Health (EHC) stake by 21% in Q1 2026, selling an estimated $93.6K and leaving 3,409 shares worth $330K. The position accounts for 0.01% of the portfolio, ranked #1232.

Tower Research Capital (TRC) first reported a position in EHC in Q3 2013 and has held it in 47 quarters since. The position peaked at $2.18M in Q3 2020. 577 funds tracked by Wall St. Rank hold EHC as of Q1 2026.

  • Tower Research Capital (TRC) held 3,409 shares of Encompass Health worth $330K as of Q1 2026.
  • Tower Research Capital (TRC) sold 913 Encompass Health shares in Q1 2026, an estimated $93.6K.
  • Encompass Health made up 0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #1232 holding.
  • Tower Research Capital (TRC) first reported a position in Encompass Health in Q3 2013 and has held it in 47 quarters since.
  • Tower Research Capital (TRC)'s Encompass Health position peaked at $2.18M in Q3 2020.
  • 577 funds tracked by Wall St. Rank held Encompass Health as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.